Canopy Growth (CGC) has broken out on the upside of a base pattern on the charts. We looked at CGC earlier this month on November 5 and I was not yet convinced of the upside, writing that "The legal landscape for the cannabis industry has improved but the charts of CGC still need more work to convince me that a sustained advance is ready to begin."
More from Investing
Here's what I found most positive about the market as the week closed out.
I like to identify a chart or two with a nice setup into the next week, and OB falls into that category.
AdvisorShares Psychedelics ETF, which is adding Mindset Pharma and lists Cybin as a top holding, looks like a good trip.